Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.2825    0.0025 (0.89%)
Bid:
0.275
Ask:
0.29
Spread: 0.015 (5.455%)
Market Cap: £21.96m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Director/PDMR Shareholding

1 Mar 2022 17:26

RNS Number : 2782D
Haydale Graphene Industries PLC
01 March 2022
 

For immediate release

1 March 2022

 

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

 

Director/PDMR Shareholding

 

Haydale, (AIM: HAYD), the global advanced materials group, has today been informed that Mark Chapman, Chief Financial Officer of the Company has transferred 285,714 ordinary shares of 2p each in the Company ("Ordinary Shares") from his personal holding into his ISA. Following this transaction Mr Chapman's interest in Company remains unchanged.

 

For further information:

 

Haydale Graphene Industries plc

Keith Broadbent, Chief Executive Officer

Mark Chapman, Chief Financial Officer

Tel: +44 (0) 1269 842 946

 

finnCap (Nominated Adviser & Broker)

Julian Blunt/Edward Whiley, Corporate Finance

Andrew Burdis, ECM

Tel: +44 (0) 20 7220 0500 

 

 

 

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Jonathan Mark Chapman

2

Reason for notification

 

 

a.

Position/Status

Chief Financial Officer of Haydale Graphene Industries plc

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Haydale Graphene Industries Plc

b.

LEI

213800KNULBQFF25IE72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 2p each

 

GB00BKWQ1135

b.

Nature of the transaction

Transfer of Shares to ISA via a sale and purchase.

c.

Price(s) and volume(s)

Price(s)

Volume(s)

 0.0440p Sale

 285,714

 0.0441p Purchase

285,714

d.

Aggregated information

 

- Aggregated Volume

 

- Price

As above

 

e.

Date of the transaction

1 March 2022

f.

Place of the transaction

AIMX - LONDON STOCK EXCHANGE - AIM MTF.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBRGDXUDGDGDB
Date   Source Headline
19th Mar 20194:31 pmRNSHolding(s) in Company
19th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
14th Mar 20197:00 amRNSDirector/PDMR Shareholding
12th Mar 201911:19 amRNSResult of General Meeting
12th Mar 20197:00 amRNSResult of Open Offer
1st Mar 201912:04 pmRNSHolding(s) in Company
27th Feb 20192:00 pmRNSPrice Monitoring Extension
26th Feb 20191:34 pmRNSHolding(s) in Company
22nd Feb 20194:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20194:35 pmRNSPrice Monitoring Extension
22nd Feb 201912:54 pmRNSResult of Placing and Subscription
22nd Feb 201911:05 amRNSSecond Price Monitoring Extn
22nd Feb 201911:00 amRNSPrice Monitoring Extension
22nd Feb 20197:01 amRNSProposed Placing and Open Offer
22nd Feb 20197:00 amRNSInterim Results
20th Feb 20192:06 pmRNSSecond Price Monitoring Extn
20th Feb 20192:00 pmRNSPrice Monitoring Extension
20th Feb 20199:00 amRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSComment on Speculation
21st Jan 20197:00 amRNSHolding(s) in Company
15th Jan 20197:21 amRNSAgreement for Functionalised Piezoresistive Ink
14th Jan 20197:00 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSDirector/PDMR Shareholding
7th Jan 20194:15 pmRNSFurther re Issue of Equity
4th Jan 201911:51 amRNSDirector/PDMR Shareholding
28th Dec 20187:00 amRNSPDMR Shareholding
21st Dec 201812:22 pmRNSResult of AGM
21st Dec 20187:00 amRNSFinance facility, issue of equity, director change
30th Nov 20184:35 pmRNSPrice Monitoring Extension
29th Nov 20187:00 amRNSAnnual Report & Notice of AGM
29th Nov 20187:00 amRNSUpdate on functionalised graphene ink sales
27th Nov 20189:31 amRNSGEIC to join Haydale and Wheelsure collaboration
27th Nov 20189:05 amRNSSecond Price Monitoring Extn
27th Nov 20189:00 amRNSPrice Monitoring Extension
26th Nov 20184:40 pmRNSSecond Price Monitoring Extn
26th Nov 20184:35 pmRNSPrice Monitoring Extension
19th Nov 20187:00 amRNSLicense agreement for anti-counterfeiting product
13th Nov 20187:00 amRNSJoint Development Agreement with Star RFID
12th Nov 201812:40 pmEQSHardman & Co Research: Haydale (HAYD): Enlightenment delayed
9th Nov 20187:00 amRNSFinancing Update
12th Oct 20187:00 amRNSDevelopment funding from Niche Vehicle Network
28th Sep 20182:54 pmRNSDirector Dealing
27th Sep 20189:29 amRNSNOTIFICATION OF MAJOR HOLDINGS
26th Sep 20185:21 pmEQSHardman & Co Research: Haydale (HAYD): Exuberance, reality; enlightenment now to follow
18th Sep 20187:00 amRNSDevelopment Contract with the EIS
18th Sep 20187:00 amRNSFull Year Results
11th Sep 20187:00 amRNSContract Updates & Notice of Results
5th Sep 20187:00 amRNSBoard Changes
13th Aug 20187:00 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.